Cargando…
Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy
BACKGROUND: Paclitaxel chemotherapy frequently induces dose-limiting sensory axonal polyneuropathy. Given that sensory symptoms are challenging to assess objectively in clinical practice, an easily accessible biomarker for chemotherapy-induced polyneuropathy (CIPN) holds the potential to improve ear...
Autores principales: | Huehnchen, Petra, Schinke, Christian, Bangemann, Nikola, Dordevic, Adam D., Kern, Johannes, Maierhof, Smilla K., Hew, Lois, Nolte, Luca, Körtvelyessy, Peter, Göpfert, Jens C., Ruprecht, Klemens, Somps, Christopher J., Blohmer, Jens-Uwe, Sehouli, Jalid, Endres, Matthias, Boehmerle, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986065/ https://www.ncbi.nlm.nih.gov/pubmed/35133982 http://dx.doi.org/10.1172/jci.insight.154395 |
Ejemplares similares
-
Assessment of Paclitaxel Induced Sensory Polyneuropathy with “Catwalk” Automated Gait Analysis in Mice
por: Huehnchen, Petra, et al.
Publicado: (2013) -
Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy
por: Huehnchen, Petra, et al.
Publicado: (2018) -
Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events
por: Müller-Jensen, Leonie, et al.
Publicado: (2023) -
Dataset for: Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC)-derived sensory neurons
por: Schinke, Christian, et al.
Publicado: (2021) -
Serum neurofilament light chain in COVID-19 and the influence of renal function
por: Körtvelyessy, Peter, et al.
Publicado: (2023)